The housing market is ripe with action, but there’s a new kind of investor – not the wealthier older Aussie, rather the ...

High gold prices are seeing an increase in M&A in the sector with the latest involving a merger of producers Alkane and Mandalay.

Telix has been shocked by the US Food & Drug Administration's rejection of marketing approval for its brain cancer diagnostic ...

ASX stocks have broadly welcomed Albanese’s critical minerals stockpile election promise but think more minerals should be ...

The ASX has jumped almost 1pc in early trading as strength in tech stocks lifts the bourse higher, despite falling gold and ...

Recce Pharmaceuticals (ASX:RCE) has partnered with the US Army Medical Research Institute of Infectious Diseases in an R&D ...

ADX Energy has plans to boost its oil and gas resources and production in Austria and Italy to fuel Europe’s hunger for more ...

The Nasdaq’s Friday rally coupled with firming oil prices have driven tech and energy stocks higher, boosting the ASX 0.36pc.

Alkane (ASX:ALK) and Mandalay Resources have merged as equals, combining their assets to form a billion dollar gold-antimony company.

ASX lifts on Wall Street's rally and China's stimulus talk, but Telix cops a hit from the FDA while Lynas and Flight Centre face pressure.

Several ASX-listed medtech companies are delivering technologies that enhance clinical precision, safety, and efficiency in healthcare.

Bubalus Resources (ASX:BUS) has started its maiden diamond drilling program at the Crosbie gold project in Victoria.